Location History:
- Munich, DE (2016)
- Planegg, DE (2020)
Company Filing History:
Years Active: 2016-2025
Title: Innovator Spotlight: Konstantin Petropoulos
Introduction
Konstantin Petropoulos is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies targeting cancer. With a remarkable portfolio of three patents, Petropoulos is recognized for his groundbreaking work in antibody research.
Latest Patents
Among his notable patents, Konstantin’s latest contributions include:
1. **Antibodies against Notch 3**: This patent involves antibodies or fragments that specifically target at least one conformational epitope of a Notch 3 or mutant Notch 3 receptor, along with compositions and methods for their use.
2. **Antibody Drug Conjugates**: This invention pertains to anti-FGFR2 and FGFR4 antibodies, antibody fragments, and antibody drug conjugates, including their applications for cancer treatment.
Career Highlights
Currently, Konstantin is associated with Novartis AG, a global leader in the pharmaceutical industry. Throughout his career, he has focused on enhancing therapies for complex diseases, showcasing his commitment to advancing medical science through his inventions.
Collaborations
In his professional journey, Konstantin collaborates with esteemed colleagues, including David Jenkins and David Bryant Batt. These collaborations have fostered a rich exchange of innovative ideas and research, further propelling advancements in their respective fields.
Conclusion
Konstantin Petropoulos exemplifies the spirit of innovation and dedication within the scientific community. Through his patents and contributions at Novartis AG, he continues to impact the landscape of medicine, paving the way for novel therapeutic strategies in the fight against cancer.